359
Comparative efficacy of total joint replacement for
management of irreversible temporomandibular joint
disease: a prospective study with two different types of
prostheses
L.M. Gonzalez-Perez
∗
, E. Olmos-Juarez, B. Albarracin-Arjona,
R. Lozano-Rosado, D. Hassan-Amselem
Virgen del Rocio University Hospital, Seville, Spain
Objectives:
To evaluate outcomes achieved in patients with two
different temporomandibular joint (TMJ) prostheses.
Methods:
All patients who had a TMJ replacement (TMJR)
implanted from 2006 through 2012 were included in this three-
year prospective study. All procedures involved replacing both the
skull base component and the mandibular condyle.
Findings:
57 patients (38 females and 19 males), involving 75
TMJs with severe disease requiring reconstruction (39 unilateral,
18 bilateral) were operated on consecutively, and 68 stock pros-
theses and seven custom-made prostheses were implanted. The
mean age at surgery was 52.6
±
11.5 years in the stock group and
51.8
±
11.7 years in the custom-made group. In the stock group,
after three years of TMJR, results showed a reduction in pain inten-
sity from 6.4
±
1.4 to 1.6
±
1.2 (
P
< 0.001), and an improvement
in jaw opening from 2.7
±
0.9 cm to 4.2
±
0.7 cm (
P
< 0.001).
In the custom-made group, after three years of TMJR, results
showed a reduction in pain intensity from 6.0
±
1.6 to 2.2
±
0.4
(
P
< 0.001), and an improvement in jawopening from1.5
±
0.5 cm
to 4.3
±
0.6 cm (
P
< 0.001). No statistically significant differences
between two groups were detected.
Conclusion:
The results of this prospective study support the sur-
gical placement of TMJ prostheses, and show that the approach is
efficacious and safe, reduces pain, and improves maximum mouth
opening movement. As such, TMJR represents a viable technique
and a stable long-term solution in patients with irreversible end-
stage TMJ disease. Comparing stock and custom-made groups, no
statistically significant differences were detected with respect to
pain intensity reduction and maximum mouth opening improve-
ment.
http://dx.doi.org/10.1016/j.ijom.2017.02.1207Role of pro-inflammation factors in the pathogenesis of
temporomandibular joint ankylosed bone mass formation
L.H. He
∗
, E. Xiao, L. Zhao, Y. He, Y. Zhang
Peking University School and Hospital of Stomatology, China
Background:
Temporomandibular joint ankylosis (TMJA) is a
severe TMJ disease which leads to progressive mouth-opening
inability while the pathological mechanisms of TMJ ankylosed
bone mass formation are not fully clear. Previous studies had
shown that pro-inflammation factors-induced osteoclastogenesis
played important roles during bone healing and the inhibition
of osteoclastogenesis during fracture healing will lead to hyper-
trophy callus formation. Our previous results had suggested that
osteoclasts deficiencymight contribute to hypertrophy TMJAbone
mass formation. However, themechanisms of osteoclast decreased
in TMJA bone mass, and how pro-inflammation factors involved
was not clear.
Objectives:
To explore the role of pro-inflammation factors in the
pathogenesis of TMJA bone mass formation.
Methods:
14 TMJA patients were recruited in this study and clas-
sified into four groups according to the Sawhney classification.
The healthy mandibles were considered as control group. The pro-
inflammation factors expressions
in vivo
and
in vitro
and the effects
of pro-inflammation factors deficiency on osteoclastogenesis were
assessed.
Results:
The pro-inflammation factors, tumour necrosis factor-
alpha (TNF- ), interleukin (IL)-6 and IL-17 were dramatically
decreased while anti-inflammation factors, IL-10 and transfor-
ming growth factor-beta 1, were increased in TMJA bone mass.
The histological results showed that TNF- and IL-17 were abun-
dant in early-progressed TMJA bone mass and decreased with
the TMJA severity accompanied with reduced osteoclastogene-
sis. The osteoclast differentiation ability was impaired in bone
marrow monocytes derived from TMJA bone mass and TNF-
partially rescued the osteoclast differentiation inhibition of TMJA
bone marrow monocytes.
Conclusion:
Decreased pro-inflammation factors might inhibit
osteoclast-mediated bone resorption and progressively contribute
to TMJ ankylosed bone formation.
http://dx.doi.org/10.1016/j.ijom.2017.02.1208Minimally invasive surgery in the management of
submandibular sialolithiasis: an audit between 1997 and
2015
A. Hills
∗
, A. Holden, C. Man, M. Samani, M. McGurk
Guy’s Hospital, London, United Kingdom
Background:
We present a single surgeon, 18-year retrospective
experience of minimally invasive gland sparing techniques.
Objectives:
Review of treatment outcomes.
Methods:
Between 1997 and 2015 patients with submandibular
sialoliths were assessed using ultrasonography, sialography and
plain radiography to identify stone size, location, number and stri-
ctures. Mobile stones under 5 mm were retrieved endoscopically
or radiographically. Stones between 5–7 mm were considered for
lithotripsy, unless they had strictures, recurrent infections or pre-
viously failed lithotripsy. Those unsuitable or greater than 7 mm
were treated surgically under general anaesthesia as day-case pro-
cedures. If the stone was within the gland then submandibular
gland excision was performed, otherwise a minimally invasive
gland sparing technique was used. Data was collected retrospec-
tively from surgical databases and patient records, all patients
were followed up in clinic and further reviewed with postal and
telephone questionnaires.
Results:
378 patients had 434 stones removed, with a 94%
(
n
= 356) successful retrieval rate. Mean stone size was 8.5 mm
(range, 1–32). Of those successfully removed 92 were with
endoscopy, 256 had minimally invasive gland sparing surgery,
and 12 had submandibular gland excision. Average inpatient stay
was 0.9 days. Mean follow up was 12.8 months. Three had intra-
operative lingual nerve injury with paraesthesia. Postoperative
complications occurred in 85 patients; 59 experienced paraesthe-
sia, 11 infections, 9 pain, and 7 developed Ranula. 20 had recurrent
symptoms following surgery. Complications were associated with
stones >9 mm, previous infection or pre-existing strictures.




